Lista de obras -

3-Dimensional microarray analysis of estrogen signal-related genes in breast cancer tissues.

artículo científico

99mTc-phytate is better than 99mTc-human serum albumin as a radioactive tracer for sentinel lymph node biopsy in breast cancer

artículo científico publicado en 2006

A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study

artículo científico publicado en 2018

A multicenter prospective study to evaluate bone fracture related to adjuvant anastrozole in Japanese postmenopausal women with breast cancer: two-year interim analysis of Saitama Breast Cancer Clinical Study Group (SBCCSG-06) ⬇️

artículo científico publicado el 12 de enero de 2013

Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer

artículo científico publicado en 2006

Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant c

article

Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer.

artículo científico publicado en 2012

Application of a rhomboid flap for the coverage of defects after malignant breast tumor resection: A case report

artículo científico publicado en 2017

Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies

artículo científico publicado en 2009

BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy

artículo científico publicado en 2017

Breast-conserving surgery following radiation therapy of 50 Gy in stages I and II carcinoma of the breast: the experience at one institute in Japan

scientific article published on 01 September 2002

Breast-conserving therapy versus modified radical mastectomy in the treatment of early breast cancer in Japan

artículo científico publicado en 2002

Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy ⬇️

artículo científico publicado en 2016

Collagen gel droplet-embedded culture-drug sensitivity test and Ki67 expression in estrogen receptor-positive and HER2-negative breast cancer

artículo científico publicado en 2012

Complication analysis of complete versus partial coverage of tissue expanders using serratus anterior musculofascial flaps in immediate breast reconstruction

artículo científico publicado en 2018

Correction to: Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition)

scientific article published on 19 May 2020

Current trends of sentinel lymph node biopsy for breast cancer--a surgeon's perspective.

artículo científico publicado en 2007

DPD activity and immunohistochemical DPD expression in human breast cancer.

artículo científico publicado en 2004

ER, PgR, Ki67, p27(Kip1), and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide

artículo científico publicado en 2015

ER-activating ability of breast cancer stromal fibroblasts is regulated independently of alteration of TP53 and PTEN tumor suppressor genes ⬇️

artículo científico publicado el 12 de octubre de 2012

Efficacy and tolerability of controlled-release oxycodone against nab-paclitaxel-induced musculoskeletal pain in breast cancer patients

artículo científico publicado en 2013

Efficacy of rhomboid flap reconstruction after mastectomy for locally advanced breast cancer

artículo científico publicado en 2020

Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction

artículo científico publicado en 2008

Evaluating the 21-gene assay Recurrence Score® as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer

artículo científico publicado en 2013

Human leukocyte antigen as a predictive factor of developing bilateral breast cancer in Japanese women

artículo científico publicado en 2006

Immunohistochemical assessment of primary breast tumors and metachronous brain metastases, with particular regard to differences in the expression of biological markers and prognosis ⬇️

artículo científico publicado el 1 de julio de 2010

Immunohistochemical study of the relationship between Ki-67 labeling index of proliferating cells of gynecomastia, histological phase and duration of disease

artículo científico publicado en 2006

Impact of immediate breast reconstruction on postoperative adjuvant chemotherapy: a single center study

artículo científico

Individual transcriptional activity of estrogen receptors in primary breast cancer and its clinical significance ⬇️

artículo científico publicado el 30 de octubre de 2012

Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma

artículo científico publicado en 2012

Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer.

artículo científico publicado en 2009

Ki67 immunohistochemical staining: the present situation of diagnostic criteria

artículo científico publicado el 1 de septiembre de 2012

Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03).

artículo científico publicado en 2007

Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial ⬇️

artículo científico publicado el 20 de enero de 2012

Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?

artículo científico publicado en 2010

Nipple adenoma found in a mastectomy specimen: report of a case with special regard to the proliferation pattern

article

Optimal treatment duration of neoadjuvant endocrine therapy in women aged 60 years or older with estrogen receptor-positive, HER2-negative invasive breast cancer

artículo científico publicado en 2020

Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer

artículo científico publicado en 2011

Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer

artículo científico publicado en 2009

Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients

artículo científico publicado en 2003

Prognostic value of the ubiquitin ligase carboxyl terminus of the Hsc70-interacting protein in postmenopausal breast cancer

artículo científico publicado en 2016

Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer

scientific article published on 01 January 2007

Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer ⬇️

artículo científico publicado el 19 de agosto de 2011

Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation ⬇️

artículo científico publicado el 16 de mayo de 2012

Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer

artículo científico publicado en 2006

Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases

artículo científico publicado en 2002

Significance and problems of histopathological examination and utility of real-time reverse transcriptase-polymerase chain reaction method for the detection of sentinel lymph node metastasis in breast cancer

artículo científico publicado en 2007

Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study

artículo científico publicado en 2016

The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy

artículo científico publicado en 2014

The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races

artículo científico publicado en 2007

The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells.

artículo científico publicado en 2006

The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways

artículo científico publicado en 2009

Tolerability and safety of docetaxel plus cyclophosphamide as adjuvant chemotherapy for axillary lymph node-negative breast cancer--JECBC04 trial

artículo científico publicado en 2010

True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment

artículo científico publicado en 2009

Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer

artículo científico publicado en 2005

[Clinicopathological characteristics of familial breast cancer]

artículo científico publicado en 2007

[Efficacy of oxycodone against anti-cancer agent-induced pain in breast cancer patients during adjuvant treatment before and after surgery]

artículo científico publicado en 2011

[Multicenter phase II trial of thrice-weekly docetaxel and weekly trastuzumab as preoperative chemotherapy in patients with HER 2-overexpressing breast cancer--Japan East Cancer Center Breast Cancer Consortium (JECBC) 02 Trial]

scientific article published on 01 October 2006

Lista de obras de

3-Dimensional microarray analysis of estrogen signal-related genes in breast cancer tissues.

99mTc-phytate is better than 99mTc-human serum albumin as a radioactive tracer for sentinel lymph node biopsy in breast cancer

A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study

A multicenter prospective study to evaluate bone fracture related to adjuvant anastrozole in Japanese postmenopausal women with breast cancer: two-year interim analysis of Saitama Breast Cancer Clinical Study Group (SBCCSG-06) ⬇️

Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer

Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant c

Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer.

Application of a rhomboid flap for the coverage of defects after malignant breast tumor resection: A case report

Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies

BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy

Breast-conserving surgery following radiation therapy of 50 Gy in stages I and II carcinoma of the breast: the experience at one institute in Japan

Breast-conserving therapy versus modified radical mastectomy in the treatment of early breast cancer in Japan

Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy ⬇️

Collagen gel droplet-embedded culture-drug sensitivity test and Ki67 expression in estrogen receptor-positive and HER2-negative breast cancer

Complication analysis of complete versus partial coverage of tissue expanders using serratus anterior musculofascial flaps in immediate breast reconstruction

Correction to: Histological classification of breast tumors in the General Rules for Clinical and Pathological Recording of Breast Cancer (18th edition)

Current trends of sentinel lymph node biopsy for breast cancer--a surgeon's perspective.

DPD activity and immunohistochemical DPD expression in human breast cancer.

ER, PgR, Ki67, p27(Kip1), and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide

ER-activating ability of breast cancer stromal fibroblasts is regulated independently of alteration of TP53 and PTEN tumor suppressor genes ⬇️

Efficacy and tolerability of controlled-release oxycodone against nab-paclitaxel-induced musculoskeletal pain in breast cancer patients

Efficacy of rhomboid flap reconstruction after mastectomy for locally advanced breast cancer

Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction

Evaluating the 21-gene assay Recurrence Score® as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer

Human leukocyte antigen as a predictive factor of developing bilateral breast cancer in Japanese women

Immunohistochemical assessment of primary breast tumors and metachronous brain metastases, with particular regard to differences in the expression of biological markers and prognosis ⬇️

Immunohistochemical study of the relationship between Ki-67 labeling index of proliferating cells of gynecomastia, histological phase and duration of disease

Impact of immediate breast reconstruction on postoperative adjuvant chemotherapy: a single center study

Individual transcriptional activity of estrogen receptors in primary breast cancer and its clinical significance ⬇️

Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma

Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer.

Ki67 immunohistochemical staining: the present situation of diagnostic criteria

Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03).

Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial ⬇️

Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?

Nipple adenoma found in a mastectomy specimen: report of a case with special regard to the proliferation pattern

Optimal treatment duration of neoadjuvant endocrine therapy in women aged 60 years or older with estrogen receptor-positive, HER2-negative invasive breast cancer

Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer

Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer

Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients

Prognostic value of the ubiquitin ligase carboxyl terminus of the Hsc70-interacting protein in postmenopausal breast cancer

Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer

Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer ⬇️

Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation ⬇️

Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer

Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases

Significance and problems of histopathological examination and utility of real-time reverse transcriptase-polymerase chain reaction method for the detection of sentinel lymph node metastasis in breast cancer

Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study

The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy

The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races

The regulatory effect of tamoxifen on fibronectin expression in estrogen-dependent MCF-7 breast carcinoma cells.

The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways

Tolerability and safety of docetaxel plus cyclophosphamide as adjuvant chemotherapy for axillary lymph node-negative breast cancer--JECBC04 trial

True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment

Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer

[Clinicopathological characteristics of familial breast cancer]

[Efficacy of oxycodone against anti-cancer agent-induced pain in breast cancer patients during adjuvant treatment before and after surgery]

[Multicenter phase II trial of thrice-weekly docetaxel and weekly trastuzumab as preoperative chemotherapy in patients with HER 2-overexpressing breast cancer--Japan East Cancer Center Breast Cancer Consortium (JECBC) 02 Trial]